Targeting glioblastoma with NK cells and mAb against NG2/CSPG4 prolongs animal survival-Reference-Cited by-同舟云学术

Targeting glioblastoma with NK cells and mAb against NG2/CSPG4 prolongs animal survival

Published:2013-09-09 Issue:9 Volume:4 Page:1527-1546
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

Poli Aurélie¹²,Wang Jian¹,Domingues Olivia²,Planagumà Jesús¹,Yan Tao¹³,Rygh Cecilie Brekke¹,Skaftnesmo Kai Ove¹,Thorsen Frits¹,McCormack Emmet⁴,Hentges François²,Pedersen Paal Henning⁵,Zimmer Jacques²,Enger Per Øyvind¹⁵,Chekenya Martha¹⁶

Affiliation:

1. Translational Cancer Research, Department of Biomedicine, University of Bergen, Norway

2. Laboratoire d'Immunogénétique-Allergologie, CRP-Santé, Luxembourg

3. Department of Neurosurgery, Qilu Hospital, Shandong University, P.R. China

4. Department of Medicine, Haukeland University Hospital, Bergen, Norway

5. Department of Neurosurgery, Haukeland University Hospital, Bergen, Norway

6. Department of Clinical Dentistry, University of Bergen, Norway

Publisher

Impact Journals, LLC

Subject

Oncology

Cited by 91 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Chondroitin sulfate proteoglycan 4: An attractive target for antibody-based immunotherapy;Proceedings of the Japan Academy, Series B;2024-05-10

2. C-Myc/H19/miR-29b axis downregulates nerve/glial (NG)2 expression in glioblastoma multiforme;Molecular Therapy - Nucleic Acids;2024-03

3. Interaction, immune infiltration characteristics and prognostic modeling of efferocytosis-related subtypes in glioblastoma;BMC Medical Genomics;2023-10-18

4. Engineering the glioblastoma microenvironment using TLR7/8 agonist-complexed graphene oxide nanosheets;2023-09-18

5. CAR-NK cell therapy for glioblastoma: what to do next?;Frontiers in Oncology;2023-06-19